Betahistine HCL is an Anti Vertigo drug and a world leader in treatment of Meniere’s disease and Vestibular vertigo. Betahistine HCL directly stimulates the h1 receptors located in blood vessels in inner ear. This would give rise to local vasodilatation and permeability, which can relieve pressure from excess fluid and act on the smooth muscles, which would help reverse the underlying problem of Endolymphatic hydrops
Molecular structure :
CAS Number:
5579-84-0
Molecular formula:
C8H12N2 2HCL
Application:
Anti Vertigo (Meniere’s disease) and Anti-Nauseants (Nausea disease)
Advantage:
It is a Non sedating Drug, so patients can remain alert and maintain their active life style.
Drug’s success rate is more than 80 %.
Betahistine only a basic long term treatment which has no habituation
and still is active in controlling Meniere’s disease even after a long
term period.
Betahistine produces no modification and effect on the evolution of deafness.
)